| OA09.03 | Impact of HLA-II associated HIV-1 adaptations on vaccine-induced CD4 T-cell immune responses | Oral Abstract Session | Cellular immunity |
| OA09.02 | Anti-Env antibody-independent protection of repeated intrarectal low-dose SIVmac239 challenges in rhesus macaques by vaccination inducing Gag/Vif-specific CD8+ T but not CD4+ T cells | Oral Abstract Session | Mucosal immunity |
| OA09.01 | BCG.HTI2auxo.int priming vaccination enhances the HIV-1 specific T cell immune responses elicited by MVA.HTI | Oral Abstract Session | Novel vaccine and other prevention approaches |
| OA08.05LB | Development of a novel VRC01-class germline targeting immunogen derived from anti-idiotypic antibodies | Oral Abstract Session | Novel vaccine and other prevention approaches |
| OA08.04 | Active tuberculosis co-infection enhances HIV-1 specific humoral immunity | Oral Abstract Session | Humoral immunity |
| OA08.03 | Combinations of scFv of HIV bNAbs demonstrate high breadth and potency against a multiclade panel of viruses | Oral Abstract Session | Broadly neutralizing antibodies |
| OA08.02 | Vaccination induces maturation of diverse unmutated VRC01-class precursors to HIV-1 broadly neutralizing antibodies in an Ig-humanized mouse model | Oral Abstract Session | Broadly neutralizing antibodies |
| OA08.01 | Antibody isotype switching as a mechanism to counter HIV neutralization escape | Oral Abstract Session | Humoral immunity |
| OA07.05LB | High initiation and persistence on pre-exposure prophylaxis (PrEP) in HIV-uninfected pregnant women in Cape Town, South Africa | Oral Abstract Session | Implementation science, including structural interventions, PrEP & VMMC |
| OA07.04 | I'm taking PrEP for myself and not for people: PrEP disclosures influence adherence journeys for adolescent girls and young women in South Africa | Oral Abstract Session | Behavioural and social science research |